[Young women with atypical endometrial hyperplasia or endometrial adenocarcinoma stage I: will conservative treatment allow pregnancy? Results of a French multicentric survey]

Gynecol Obstet Fertil. 2006 Jan;34(1):27-33. doi: 10.1016/j.gyobfe.2005.11.005. Epub 2006 Jan 6.
[Article in French]

Abstract

Objectives: To analyse the carcinological and obstetrical results of young women with atypical endometrial hyperplasia or endometrial adenocarcinoma, treated in a conservative way to allow pregnancy.

Patients and methods: A retrospective analysis of 13 cases (5 adenocarcinomas and 8 atypical hyperplasias) followed in 8 French centers between 1997 and 2004.

Results: After 4.6 months of conservative treatment, there were no residual lesions in 61.5% of the cases. Progestatives seem to be the most effective treatment. Tumoral regression makes it possible to plan a pregnancy, with childbirth in 25% of the cases. In these frequently infertile patients, all the techniques of assisted reproduction can be used. Recurrences are not rare after hormonal treatment (37.5%), so, total hysterectomy is justified after delivery.

Discussion and conclusion: Conservative treatment for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma stage I can be considered in some cases to enable pregnancy.

Publication types

  • English Abstract
  • Multicenter Study

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / surgery
  • Adult
  • Endometrial Hyperplasia / drug therapy*
  • Endometrial Hyperplasia / surgery
  • Endometrial Neoplasms / drug therapy*
  • Endometrial Neoplasms / surgery
  • Female
  • Humans
  • Infertility / etiology*
  • Infertility / prevention & control
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Pregnancy
  • Pregnancy Complications, Neoplastic / therapy*
  • Pregnancy Outcome
  • Progestins / therapeutic use
  • Reproductive Techniques, Assisted
  • Retrospective Studies

Substances

  • Progestins